ES2136206T3 - Composicion antibacteriana que contiene alfalactalbumina multimerica. - Google Patents

Composicion antibacteriana que contiene alfalactalbumina multimerica.

Info

Publication number
ES2136206T3
ES2136206T3 ES94928519T ES94928519T ES2136206T3 ES 2136206 T3 ES2136206 T3 ES 2136206T3 ES 94928519 T ES94928519 T ES 94928519T ES 94928519 T ES94928519 T ES 94928519T ES 2136206 T3 ES2136206 T3 ES 2136206T3
Authority
ES
Spain
Prior art keywords
multimerica
alfalactalbumina
composition containing
antibacterial composition
lactalbumin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94928519T
Other languages
English (en)
Inventor
Hemant Sabharwal
Catharina Svanborg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2136206T3 publication Critical patent/ES2136206T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A23J3/10—Casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/24—Extraction; Separation; Purification by electrochemical means
    • C07K1/26—Electrophoresis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/285—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Electrochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)

Abstract

LA PRESENTE INVENCION HACE REFERENCIA AL USO DE ALFALACTALBUMINA MULTIMERICA EN LA PREPARACION DE PREPARACIONES A USAR EN EL TRATAMIENTO TERAPEUTICO O PROFILACTICO Y/O PARA EL USO DIAGNOSTICO DE INFECCIONES, PREFERIBLEMENTE DEL TRACTO RESPIRATORIO, CAUSADAS POR BACTERIAS, EN PARTICULAR S. PNEUMONIAE Y/O H. INFLUENZAE.
ES94928519T 1994-08-16 1994-08-16 Composicion antibacteriana que contiene alfalactalbumina multimerica. Expired - Lifetime ES2136206T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SE1994/000742 WO1996004929A1 (en) 1994-08-16 1994-08-16 Antibacterial composition containing multimeric alpha-lactalbumin

Publications (1)

Publication Number Publication Date
ES2136206T3 true ES2136206T3 (es) 1999-11-16

Family

ID=20393168

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94928519T Expired - Lifetime ES2136206T3 (es) 1994-08-16 1994-08-16 Composicion antibacteriana que contiene alfalactalbumina multimerica.

Country Status (11)

Country Link
US (2) US6599874B1 (es)
EP (1) EP0776214B1 (es)
JP (1) JP3694319B2 (es)
AT (1) ATE182470T1 (es)
AU (1) AU7792294A (es)
CA (1) CA2197659C (es)
DE (1) DE69419782T2 (es)
DK (1) DK0776214T3 (es)
ES (1) ES2136206T3 (es)
GR (1) GR3031078T3 (es)
WO (1) WO1996004929A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968901A (en) * 1989-10-30 1999-10-19 Andersson; Bengt Antibacterial composition
GB9724725D0 (en) * 1997-11-21 1998-01-21 Svanborg Catharina Protein production process
DK1032596T3 (da) * 1997-11-21 2007-09-10 Nya Hamlet Pharma Ab Fremgangsmåde til fremstilling af lactalbumin
GB9725126D0 (en) * 1997-11-27 1998-01-28 Svanborg Catharina Therapeutic agents
US6815419B1 (en) * 1999-07-28 2004-11-09 Morinaga Milk Industry Co., Ltd. Antiulcer agent
RU2305547C2 (ru) 2001-08-23 2007-09-10 Вестгейт Байолоджикал Лимитед Применение апопротеинов сыворотки молока в профилактике или лечении микробной или вирусной инфекции
GB0210464D0 (en) 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
CN102590413B (zh) * 2012-01-18 2013-12-25 浙江省疾病预防控制中心 一种牛α-乳白蛋白的定量检测方法
HUE038910T2 (hu) 2012-08-09 2018-12-28 Hamlet Pharma Ab Profilaktikus és gyógytáp terápia
CN120239612A (zh) 2022-10-03 2025-07-01 林南制药公司 一种用于治疗或预防癌症的包含α-乳清蛋白和脂肪酸或脂质的复合物
GB202303177D0 (en) 2023-03-03 2023-04-19 Linnane Pharma Ab Method of predicting response to treatment
WO2025186107A1 (en) 2024-03-04 2025-09-12 Linnane Pharma Ab Therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459619B1 (fr) * 1979-06-26 1983-07-29 Agronomique Inst Nat Rech Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede
EP0058665B1 (en) 1980-05-09 1986-02-26 LEFFLER, Hakon Carbohydrate derivatives for inhibiting bacterial adherence
CA1333471C (en) * 1988-04-29 1994-12-13 Gustavo Bounous Whey protein concentrate as food supplement
US5968901A (en) * 1989-10-30 1999-10-19 Andersson; Bengt Antibacterial composition
US5795611A (en) 1989-12-20 1998-08-18 Slattery; Charles W. Human infant formulas containing recombinant human alpha-lactalbumin and beta-casein
JP2961625B2 (ja) * 1991-01-21 1999-10-12 雪印乳業株式会社 α−ラクトアルブミン含有量の高い組成物の製造方法

Also Published As

Publication number Publication date
CA2197659A1 (en) 1996-02-22
DK0776214T3 (da) 1999-11-29
EP0776214B1 (en) 1999-07-28
JPH10504547A (ja) 1998-05-06
DE69419782T2 (de) 1999-12-23
DE69419782D1 (de) 1999-09-02
ATE182470T1 (de) 1999-08-15
AU7792294A (en) 1996-03-07
WO1996004929A1 (en) 1996-02-22
US6599874B1 (en) 2003-07-29
US7144855B2 (en) 2006-12-05
GR3031078T3 (en) 1999-12-31
US20040106541A1 (en) 2004-06-03
CA2197659C (en) 2009-11-10
EP0776214A1 (en) 1997-06-04
JP3694319B2 (ja) 2005-09-14

Similar Documents

Publication Publication Date Title
DE3462255D1 (en) Quinolone carboxylic acids, process for their preparation and antibacterial compositions containing them
DE69430823D1 (de) Verfahren zur behandlung von gram-negativen bakterien infektion durch verabreichung von bakterientötendem/durchlässigkeiterhöhendem (bpi) proteinprodukt und antibiotikum
CA2189658A1 (en) Controlled-Release Dosage Forms of Azithromycin
BG101118A (en) Therapeutical compounds
DE59710183D1 (de) Topische mittel zur prophylaxe oder behandlung bakterieller hautinfektionen
DE69419782D1 (de) Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzung
ATE277063T1 (de) 6-o-alkylerythromycinoxim b
EE200000587A (et) Uued 15-lülilised ketoasaliidid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline kompositsioon kasutamiseks bakternakkuste ravis
WO2000058475A3 (en) Streptococcus pneumoniae antigens
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
KR880701734A (ko) 글리코 펩티드 항생물질
SE8903625L (sv) Antibacterial composition
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
CLARKE TOPICAL USE OF SILVER SULPHADIAZINE AND CHLORHEXIDINE IN THW PREVENTION OF INFECTION IN THERMAL INJURIES
DE69739775D1 (de) Verabreichung von Produkten des 5-lipoxygenase Synthesewegs zur Behandlung von mikrobiellen Infektionen
Ginsburg Streptococcus.
DE3260277D1 (en) Peptide antibiotic, component b, process for its preparation and its use in medicines
WO2000015207A3 (en) Combination for the treatment of inflammation using elastine inhibitor(s) and antibacterial agent(s)
Lawrence Infection control in burns
WO1998021231A3 (en) Streptococcus uberis lactoferrin-binding protein
JPS57142999A (en) Antibiotic compound, manufacture and medical use
McDougall Burns and the Use of Silver Sulphadiazine 1
Scatizzi et al. Prevention of Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis
FR2307542A1 (fr) Nouvelle preparation immunostimulante
Lechi et al. Clinical evaluation of ceftazidime in the treatment of infections caused by Pseudomonas and other gram-negative bacteria.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 776214

Country of ref document: ES